Dialysis News and Research

Latest Dialysis News and Research

Study compares clinical outcomes of Ellipsys and WavelinQ-4F pAVF devices

Two devices for creating minimally invasive dialysis access--the Ellipsys® Vascular Access System and the WavelinQ™ 4F System--demonstrated high rates of technical success and low rates of complications, according to a new study published in the Journal of Vascular and Interventional Radiology.

10 Sep 2020

In legislative shuffle, California prioritizes safety gear and sick leave during crisis

California lawmakers convened this year with big plans to tackle soaring health care costs, expand health insurance coverage and improve treatment for mental health and addiction.

4 Sep 2020

Ellipsys Vascular Access System reduces time for dialysis treatments

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study led by interventional radiologist Jeffrey Hull, M.D., of Richmond Vascular Center.

3 Sep 2020

Why Black aging matters, too

Old. Chronically ill. Black. People who fit this description are more likely to die from COVID-19 than any other group in the country.

3 Sep 2020

Active lifestyle choices can lower the risk of chronic kidney disease

Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports.

2 Sep 2020

SGLT2 inhibitors can slow CKD progression

850 million people worldwide are affected by chronic kidney disease (CKD) - a worrying figure, and one that continues to rise.

31 Aug 2020

$Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction$

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction.

31 Aug 2020

Dialysis patients have higher risk for SARS-CoV-2 infection, study suggests

It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.

25 Aug 2020

New surgical technique could lead to better dialysis outcomes

A new technique developed by a Yale-led research team improves blood flow in surgically made blood vessels used in dialysis, enables them to last longer, and results in fewer complications than the standard technique.

20 Aug 2020

Proteinuria reduction slows kidney decline in patients with focal segmental glomerulosclerosis

Reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis (FSGS), a rare disease in which scar tissue forms on the parts of the kidneys that filter waste from the blood, can significantly slow declines in kidney function and extend time before patients' kidneys fail, a new analysis by a Children's National Hospital researcher and her colleagues shows.

10 Aug 2020

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) varies depending on the type of mutation in the syndrome's causal gene (COL4A5).

7 Aug 2020

Marshall University researcher awarded NIH grant to study uremic cardiomyopathy

Komal Sodhi, M.D., an associate professor of surgery and biomedical sciences at the Marshall University Joan C. Edwards School of Medicine, has been awarded a $444,000 grant from the National Institutes of Health to further her research on cardiomyopathy associated with chronic renal failure, or uremic cardiomyopathy.

6 Aug 2020

Study finds fungal isolates with high levels of virulence in different hospitals

A group of researchers from Brazil, Denmark, Italy and Spain analyzed 884 samples of fungi of the genus Candida collected from 16 hospitals and found a significant number of clusters in more than one hospital.

29 Jul 2020

Inconsistent SARS-CoV-2 antibody results in nephrology workers

Using a broad spectrum of antibody tests the present study revealed inconsistent results for SARS-CoV-2 seroprevalence among asymptomatic individuals, while this was not the case among Covid-19 patients.

29 Jul 2020

Study shows safety of kidney transplantation between people with HIV

Kidney transplantation from deceased donors with HIV to people living with both HIV and end-stage kidney disease is feasible and safe, investigators supported by the National Institutes of Health have found.

23 Jul 2020

The American Society of Nephrology and HHS announce winners of kidneyx redesign dialysis competition

Today, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the six winners of the $3 million KidneyX: Redesign Dialysis Phase 2 competition during the virtual KidneyX Summit.

23 Jul 2020

Ellipsys System can help create durable vascular access for end-stage renal disease

A new study shows significant benefits of the Ellipsys Vascular Access System in easily and safely creating durable vascular access for end-stage renal disease (ESRD) patients who require hemodialysis.

21 Jul 2020

Researchers identify underlying mechanism for metabolic memory and diabetic complications

For people with diabetes, vascular complications like kidney disease and atherosclerosis, which can lead to poor health and even death, are seen at increased rates.

20 Jul 2020

Including patients' preferences in kidney allocation system could improve outcomes

From the moment a kidney becomes available, there are just 24 hours to identify the recipient and carry out the transplant.

17 Jul 2020

Study shows immediate dialysis is no better than the conservative approach

In the largest international study of its kind, researchers at the University of Alberta and Toronto's St. Michael's Hospital found that an accelerated renal-replacement therapy strategy did not reduce mortality after three months, compared to a standard strategy for critically ill patients with acute kidney injury.

17 Jul 2020

Dialysis News and Research

Latest Dialysis News and Research

Study compares clinical outcomes of Ellipsys and WavelinQ-4F pAVF devices

In legislative shuffle, California prioritizes safety gear and sick leave during crisis

Ellipsys Vascular Access System reduces time for dialysis treatments

Why Black aging matters, too

Active lifestyle choices can lower the risk of chronic kidney disease

SGLT2 inhibitors can slow CKD progression

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Dialysis patients have higher risk for SARS-CoV-2 infection, study suggests

New surgical technique could lead to better dialysis outcomes

Proteinuria reduction slows kidney decline in patients with focal segmental glomerulosclerosis

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

Marshall University researcher awarded NIH grant to study uremic cardiomyopathy

Study finds fungal isolates with high levels of virulence in different hospitals

Inconsistent SARS-CoV-2 antibody results in nephrology workers

Study shows safety of kidney transplantation between people with HIV

The American Society of Nephrology and HHS announce winners of kidneyx redesign dialysis competition

Ellipsys System can help create durable vascular access for end-stage renal disease

Researchers identify underlying mechanism for metabolic memory and diabetic complications

Including patients' preferences in kidney allocation system could improve outcomes

Study shows immediate dialysis is no better than the conservative approach

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in